EIHSX Holdings Information

EIHSX is a mutual fund with a total of 40 individual holdings. The top holdings are Eli Lilly and Company stock at 12.37%, AbbVie at 7.20%, Johnson & Johnson at 7.10%, UnitedHealth Group at 5.79%, and AstraZeneca at 5.54%.

Total Holdings

Top 10 Percentage

59.70%

Asset Class

Equity

Fund Category

Health

Assets

779.02M

Forward PE Ratio

19.98

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	12.37%	84,287
2	ABBV	AbbVie Inc.	7.20%	224,713
3	JNJ	Johnson & Johnson	7.10%	216,808
4	UNH	UnitedHealth Group Incorporated	5.79%	109,349
5	LON: AZN	AstraZeneca PLC	5.54%	254,890
6	n/a	Roche Holding AG	5.47%	98,026
7	MRK	Merck & Co., Inc.	5.39%	324,173
8	BMY	Bristol-Myers Squibb Company	4.28%	513,118
9	VRTX	Vertex Pharmaceuticals Incorporated	3.45%	56,632
10	GILD	Gilead Sciences, Inc.	3.10%	186,232
11	TMO	Thermo Fisher Scientific Inc.	3.03%	41,239
12	ABT	Abbott Laboratories	2.72%	201,584
13	ISRG	Intuitive Surgical, Inc.	2.57%	56,833
14	EPA: SAN	Sanofi	2.45%	222,328
15	SWX: NOVN	Novartis AG	2.19%	109,500
16	SYK	Stryker Corporation	2.15%	51,623
17	SWX: LONN	Lonza Group AG	1.85%	20,771
18	CVS	CVS Health Corporation	1.82%	136,309
19	DGX	Quest Diagnostics Incorporated	1.70%	57,117
20	CPH: NOVO.B	Novo Nordisk A/S	1.69%	280,291
21	NBIX	Neurocrine Biosciences, Inc.	1.67%	78,152
22	RPRX	Royalty Pharma plc	1.59%	212,908
23	MTD	Mettler-Toledo International Inc.	1.56%	8,632
24	DHR	Danaher Corporation	1.53%	61,595
25	ARGX	argenx SE	1.40%	12,836

Showing 25 of 40 holdings

Subscribe to see the full list

Activate Now

As of Jul 31, 2026